Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Alcon Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Alcon yıllık ortalama 66.4% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 10.6% annual. Gelirler growing yılda ortalama 7% oranında artmaktadır. Alcon'in özkaynak karlılığı 5.3% ve net marjı 11.4%'dir.

Anahtar bilgiler

66.4%

Kazanç büyüme oranı

66.4%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	11.1%
Gelir büyüme oranı	7.0%
Özkaynak getirisi	5.3%
Net Marj	11.4%
Sonraki Kazanç Güncellemesi	13 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 01

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Feb 15

Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price

Dec 22

Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)

Dec 04

Calculating The Fair Value Of Alcon Inc. (VTX:ALC)

Nov 08

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Oct 18

Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger

Aug 25

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Aug 10

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Jul 05

Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist

May 12

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Apr 03

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Feb 03

Returns Are Gaining Momentum At Alcon (VTX:ALC)

Jan 19

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Dec 18

Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?

Nov 02

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

Sep 30

We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt

Sep 11

With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For

Aug 26

These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well

Jun 10

Alcon (VTX:ALC) Is Experiencing Growth In Returns On Capital

May 20

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital

Feb 13

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Dec 28

We Like These Underlying Return On Capital Trends At Alcon (VTX:ALC)

Oct 26

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Sep 15

Gelir ve Gider Dağılımı

Alcon nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SWX:ALC Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 24	9,636	1,102	3,231	836
31 Mar 24	9,562	1,048	3,226	842
31 Dec 23	9,455	974	3,209	845
30 Sep 23	9,274	450	3,177	837
30 Jun 23	9,085	362	3,141	795
31 Mar 23	8,880	341	3,112	759
31 Dec 22	8,717	335	3,068	723
30 Sep 22	8,695	571	3,131	684
30 Jun 22	8,657	457	3,145	706
31 Mar 22	8,550	460	3,125	703
31 Dec 21	8,291	376	3,076	703
30 Sep 21	8,082	332	2,980	706
30 Jun 21	7,818	183	2,884	680
31 Mar 21	6,922	-390	2,690	665
31 Dec 20	6,833	-531	2,694	675
30 Sep 20	6,806	-717	2,647	678
30 Jun 20	6,836	-636	2,662	702
31 Mar 20	7,525	-604	2,827	707
31 Dec 19	7,508	-656	2,802	690
30 Sep 19	7,386	-638	2,830	735
30 Jun 19	7,280	-779	2,827	688
31 Mar 19	7,177	-362	2,761	665
31 Dec 18	7,153	-227	2,799	653
30 Sep 18	7,123	175	2,725	527
31 Dec 17	6,792	256	2,596	545
31 Dec 16	6,596	-170	2,526	481
31 Dec 15	6,776	308	2,337	457

Kaliteli Kazançlar: ALC yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: ALC 'nin mevcut net kar marjları (11.4%) geçen yılın (4%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: ALC son 5 yılda karlı hale geldi ve kazançlarını yıllık 66.4% oranında artırdı.

Büyüme Hızlandırma: ALC 'un son bir yıldaki kazanç büyümesi ( 204.4% ) 5 yıllık ortalamasını (yıllık 66.4% ) aşıyor.

Kazançlar vs. Sektör: ALC geçen yılki kazanç büyümesi ( 204.4% ) Medical Equipment sektörünün 2.9% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: ALC 'nin Özsermaye Getirisi ( 5.3% ) düşük olarak değerlendiriliyor.

Alcon Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

First quarter 2024 earnings: EPS exceeds analyst expectations

Full year 2023 earnings: EPS exceeds analyst expectations

Third quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.30 in 2Q 2022)

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Recent updates

CEO & Director notifies of intention to sell stock

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Alcon Inc. Maintains Earnings Guidance for the Year 2024

Now 24% undervalued

Investor Optimism Abounds Alcon Inc. (VTX:ALC) But Growth Is Lacking

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

Should You Be Adding Alcon (VTX:ALC) To Your Watchlist Today?

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well

First quarter 2024 earnings: EPS exceeds analyst expectations

Upcoming dividend of CHF0.24 per share

Alcon Inc. Approves Gross Dividend

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and Its Hydrus Microstent for Microinvasive Glaucoma Surgery

Dividend of CHF0.24 announced

Alcon Inc.'s (VTX:ALC) Shareholders Might Be Looking For Exit

Alcon Announces Management Changes

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Alcon Inc. Launches Clareon Presbyopia Correcting IOLs in India

President of North America notifies of intention to sell stock

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Alcon Inc. Proposes Dividend for the Year 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Announces Positive Topline Results from Phase 3 Comet Trials of AR-15512, A Novel Topical Drug Candidate for Dry Eye

Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price

Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 08, 2024

Alcon Inc. Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Calculating The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon Inc. Showcases Cloud-Based Planning and World-Class Digital Technologies During AAO 2023

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Launches Total30 Multifocal Contact Lenses for Patients with Presbyopia

Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger

Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.30 in 2Q 2022)

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Head of Corporate Development notifies of intention to sell stock

Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Alcon Inc. Provides Earnings Guidance for the Year 2023

Alcon Announces Results from a New Study Presented at the American Society of Cataract and Refractive Surgery Annual Meeting

Alcon Inc. Approves Dividend

Upcoming dividend of CHF0.21 per share at 0.3% yield

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS misses analyst expectations

Now 21% undervalued

Alcon Inc. Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices

Alcon Launches New Total Toric Lenses for Astigmatic Patients

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Returns Are Gaining Momentum At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 05, 2023

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Now 20% undervalued

Alcon Inc. Updates Earnings Guidance for the Year 2022

Insufficient new directors

Alcon Inc. Revises Revenue Guidance for 2022

Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt

With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For

Alcon Inc. (SWX:ALC) entered into a definitive merger agreement to acquire Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI) for approximately $770 million.

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations